M. Klotsman

A case-based evaluation of SRD5A1, SRD5A2, AR, and ADRA1A as candidate genes for severity of BPH

C. Weinberg, K. Hartmann, C. Binnie, 2004, The Pharmacogenomics Journal.

Safety, Tolerability, and Proof-Of-Concept Study of OKV-119, a Novel Exenatide Long-Term Drug Delivery System, in Healthy Cats

W. Anderson, C. Gilor, C. Adin, 2021, Frontiers in Veterinary Science.

Mycophenolic acid in patients with immune‐mediated inflammatory diseases: From humans to dogs

W. Anderson, O. Garden, M. Klotsman, 2018, Journal of veterinary pharmacology and therapeutics.

Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.

L. Edwards, P. Dorinsky, E. Bleecker, 2006, The Journal of allergy and clinical immunology.

Factor analysis in the Genetics of Asthma International Network family study identifies five major quantitative asthma phenotypes

H. Ortega, K. Carlsen, K. Barnes, 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Single-dose pharmacokinetics of mycophenolic acid following administration of immediate-release mycophenolate mofetil in healthy Beagle dogs.

W. Anderson, M. Klotsman, G. Sathyan, 2021, Journal of veterinary pharmacology and therapeutics.

Pharmacokinetics and Pharmacodynamics of Immediate- and Modified-Release Mycophenolic Acid Preparations in Healthy Beagle Dogs

Amanda J. Fairchild, W. Anderson, O. Garden, 2021, Frontiers in Veterinary Science.

Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast

E. J. van den Oord, S. Pillai, W. Anderson, 2007, Pharmacogenetics and genomics.

Acute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly β2-adrenergic polymorphisms*

L. Edwards, H. Ortega, S. Yancey, 2009, Current medical research and opinion.

Acute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly beta(2)-adrenergic polymorphisms.

L. Edwards, H. Ortega, S. Yancey, 2009, Current medical research and opinion.

Drug release profile of a novel exenatide long-term drug delivery system (OKV-119) administered to cats

M. Klotsman, C. Gilor, Wayne H. Anderson, 2024, BMC veterinary research.